Proof of Principle for Crizotinib in Anaplastic Lymphoma Kinase-Positive Malignancies Was Achieved in ALK-Positive Nonclinical Models | Citedby Results | Molecular Cancer Therapeutics | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Proof of Principle for Crizotinib in Anaplastic Lymphoma Kinase-Positive Malignancies Was Achieved in ALK-Positive Nonclinical Models

Mol Cancer Ther (2011) 10 (11): 2024.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Epinephrine, Pregabalin, and Crizotinib as Three Medicines with Polish Implications over Three Last Centuries and in View of Three Different Drug Discovery Approaches

Piotr Kawczak
Igor Feszak
Tomasz Bączek

Biomedicines (2024) 12 (9): 2021.

The lonely driver or the orchestra of mutations? How next generation sequencing datasets contradict the concept of single driver checkpoint mutations in solid tumours – NSCLC as a scholarly example

Verena Schildgen
Oliver Schildgen

Seminars in Cancer Biology (2019) 58: 22.

Crizotinib Synergizes with Chemotherapy in Preclinical Models of Neuroblastoma

Kateryna Krytska
Hannah T. Ryles
Renata Sano
Pichai Raman
Nicole R. Infarinato
Theodore D. Hansel
Monish R. Makena
Michael M. Song
C. Patrick Reynolds
Yael P. Mossé

Clinical Cancer Research (2016) 22 (4): 948.

Setting up a wide panel of patient‐derived tumor xenografts of non–small cell lung cancer by improving the preanalytical steps

Marius Ilie
Manoel Nunes
Lydia Blot
Véronique Hofman
Elodie Long‐Mira
Catherine Butori
Eric Selva
Ana Merino‐Trigo
Nicolas Vénissac
Jérôme Mouroux
Patricia Vrignaud
Paul Hofman

Cancer Medicine (2015) 4 (2): 201.

Anaplastic Large Cell Lymphoma in Children and Adolescents

Eric J. Lowe
Thomas G. Gross

Pediatric Hematology and Oncology (2013) 30 (6): 509.

Potential Therapies for Anaplastic Lymphoma Kinase-Driven Tumors in Children: Progress to Date

Eric J. Lowe
Megan S. Lim

Pediatric Drugs (2013) 15 (3): 163.

Patient-derived tumour xenografts as models for oncology drug development

John J. Tentler
Aik Choon Tan
Colin D. Weekes
Antonio Jimeno
Stephen Leong
Todd M. Pitts
John J. Arcaroli
Wells A. Messersmith
S. Gail Eckhardt

Nature Reviews Clinical Oncology (2012) 9 (6): 338.